Thursday, June 03, 2021 3:54:04 PM
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160597164
Up date
Cisco has been denied a new trial after it suffered a record $1.9 billion patent case loss against Virginian start-up Centripetal Networks in October 2020.
The Nasdaq-listed tech company submitted a motion for a new trial on November 2 2020, regarding the US District Court for the Eastern District of Virginia’s rulings on US patent number 9,500,176 and 9,203,806. It also asked the court to reconsider willfulness and damages in the prior ruling.
Cisco argued that the court's decision on fixing the date of its first infringement was sua sponte - or that the court had taken notice of an issue on its own motion without prompting or suggestion from the parties involved.
However, the court said that Cisco’s damages expert, Dr. Stephen Becker, agreed that June 20, 2017 would have been the first date of infringement “for at least some of the patents at issue.”
In a response to Cisco’s motion for a new trial, district judge Henry Morgan Jr. denied Cisco’s pleas and reinstated the court’s prior ruling on March 17. He claimed the court will enter final judgment in favour of Centripetal Networks.
The timeline
Centripetal Networks first filed a complaint against Cisco Systems in February 2018, alleging infringement of 11 of its US cybersecurity patents.
In response, Cisco requested inter partes reviews for nine of the patents. The US Patent Trial and Appeal Board (PTAB) invalidated claims on several of the patents.
Proceedings went ahead on five of the patents not under inter partes review: US patent numbers 9,137,205, 9,203,806, 9,500,176, 9,686,193 and 9,917,856.
Judge Morgan issued a ruling in favour of Centripetal, finding that Cisco willfully infringed four of the five asserted patents, awarding Centripetal $1.9 billion in damages, as well as a running royalty of 10% on the apportioned sales of Cisco products related to the patents for three years.
https://www.worldipreview.com/news/cisco-request-for-new-trial-denied-after-1-9-billion-loss-21159
Recent NLST News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:32:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:31:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:15 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:54:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 02:44:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/01/2024 09:35:01 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/01/2024 09:32:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:15:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 02:38:35 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/16/2024 02:52:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 12:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2023 01:30:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/06/2023 02:22:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 08:30:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 01:30:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 09:01:19 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/15/2023 09:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:00:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/11/2023 01:53:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:45:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 12:30:22 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM